Discover how recent Bayesian network meta-analyses map the long-term efficacy thresholds of amitriptyline vs botulinum toxin ...

Amitriptyline (Amypres (25 mg)) is a tricyclic antidepressant, prescribed for depression. It is also prescribed for migraine and nerve pain. It corrects the imbalance of chemical substances acting on ...

The largest contributor to global disability is low back pain, for which various treatments are available but are of limited efficacy. International clinical guidelines recommend low-dose ...

Elavil (now discontinued) was a brand name for a generic drug called amitriptyline hydrochloride, or simply amitriptyline. Amitriptyline was also available under the brand name Endep, but the Food and ...

Despite amitriptyline missing the primary endpoint of significantly improving pain relief, disability, and work-related outcomes at 6 months for people with chronic low back pain, shorter term ...

Amitriptyline is a prescription drug available as a tablet in several strengths. It’s approved for use to treat depression but is also often prescribed for several other conditions like pain, ...

Countless people in the UK take amitriptyline on prescription to help manage long-lasting nerve pain, depression, or even to prevent migraines. But did you know that the pain-relief drug isn't always ...

Please provide your email address to receive an email when new articles are posted on . Although treatment with low-dose amitriptyline did not achieve a significant difference in improvement of pain ...

Amitriptyline can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research has found. The cheap and widely available prescription drug, which is commonly used at low ...

Amitriptyline (Dot Trip (25 mg)) is a tricyclic antidepressant, prescribed for depression. It is also prescribed for migraine and nerve pain. It corrects the imbalance of chemical substances acting on ...

A cheap and widely available prescription drug can improve symptoms of irritable bowel syndrome in patients seen in GP surgeries, new research presented today [16 October] at UEG Week 2023 has found.